Yu Waye Chu
Patrimonio netto: 107 747 $ in data 30/09/2026
Patrimonio netto: 107 747 $ in data 30/09/2026
Yu Waye Chu ricopre la posizione di vicepresidente senior dello sviluppo clinico alla Fate Therapeutics, Inc. Ha conseguito una laurea presso l'Università di Princeton e un dottorato presso la University of Rochester School of Medicine & Dentistry.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 39.613 ( 0,02% ) | 107 747 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
| FATE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 14/07/2023 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/04/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
University of Rochester School of Medicine & Dentistry
University of Rochester School of Medicine & Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale